Company Filing History:
Years Active: 2009-2011
Title: Dilek Saylik: Innovator in Anti-Thrombotic Therapy
Introduction
Dilek Saylik is a prominent inventor based in Victoria, Australia. She has made significant contributions to the field of pharmacology, particularly in the development of anti-thrombotic therapies. With a total of two patents to her name, her work is recognized for its potential impact on medical treatments.
Latest Patents
Dilek's latest patents focus on the inhibition of phosphoinositide 3-kinase β. The inventions relate to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are intended for use in anti-thrombotic therapy. The patents also describe a method for screening compounds that can be useful for new anti-thrombotic therapies by detecting the selective inhibitory activity of PI 3-kinase β. Additionally, her inventions include novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Dilek Saylik is currently employed at AstraZeneca AB, where she continues to advance her research and development efforts. Her work at AstraZeneca has positioned her as a key player in the pharmaceutical industry, contributing to innovative solutions for complex health issues.
Collaborations
Dilek has collaborated with notable colleagues, including Shaun P. Jackson and Alan Duncan Robertson. These partnerships have enhanced her research capabilities and broadened the scope of her inventions.
Conclusion
Dilek Saylik is a trailblazer in the field of anti-thrombotic therapy, with her innovative patents paving the way for new medical treatments. Her contributions to pharmacology are invaluable, and her work continues to inspire advancements in healthcare.